A disulfide-bound HIV-1 V3 loop sequence on the surface of human rhinovirus 14 induces neutralizing responses against HIV-1

Biological Chemistry

Volumn 380, Issue 3, 1999, Pages 365-374

  Zhang, Anqiang ^a,d   Geisler, Sheila C ^a   Smith, Allen D ^a,e   Resnick, Dawn A ^a,f   Li, Ming Lie ^b   Wang, Chang Yi ^b   Looney, David J ^c   Wong Staal, Flossie ^c   Arnold, Edward ^a   Arnold, Gail Ferstandig ^a  

^a RUTGERS UNIVERSITY   (United States)

^b United Biomedical Inc   (United States)

^c UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^d TTPI/FDAH   (United States)

^e BELTSVILLE HUMAN NUTRITION RESEARCH CENTER   (United States)

^f PRINCETON UNIVERSITY   (United States)

Author keywords

AIDS; Chimera; Combinatorial library; Mutagenesis; Vaccines

Indexed keywords

CAPSID PROTEIN; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; MONOCLONAL ANTIBODY; NEUTRALIZING ANTIBODY; POLYCLONAL ANTIBODY; VIRUS PROTEIN; VIRUS VACCINE;

AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANTIGENICITY; ARTICLE; CHIMERA; CONTROLLED STUDY; DISULFIDE BOND; GUINEA PIG; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN RHINOVIRUS; IMMUNOGENICITY; MOLECULAR DYNAMICS; MOLECULAR MODEL; MUTAGENESIS; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN STRUCTURE; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALIA; CAVIA PORCELLUS; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN RHINOVIRUS 14; HUMAN RHINOVIRUS SP.; MIRIDAE; SUS SCROFA;

EID: 0033008158     PISSN: 14316730     EISSN: None     Source Type: Journal    
DOI: 10.1515/BC.1999.048     Document Type: Article

References (44)

1. Arnold, E., and Rossmann, M.G. (1988). The use of molecular-re placement phases for the refinement of the human rhinovirus 14 structure. Acta Crystallogr. A44, 270-282.
2. Arnold, G.F., Resnick, D.A., Li, Y., Zhang, A., Smith, A.D., Geisler, S.C., Jacobo-Molina, A., Lee, W.-m., Webster, R.G., and Arnold, E. (1994). Design and construction of rhinovirus chimeras incorporating immunogens from polio, influenza, and human immunodeficiency viruses. Virology 198, 703-708.
3. Bruccoleri, R.E., Haber, E., and Novotny, J. (1988). Structure of antibody hypervariable loops reproduced by a conformational search algorithm. Nature 335, 564-568.
4. Catasti, P., Bradbury, E.M., and Gupta, G. (1996). Structure and polymorphism of HIV-1 third variable loops. J. Biol. Chem. 271, 8236-8242.
5. Chandrasekhar, K., Profy, A.T., and Dyson, H.J. (1991). Solution conformational preferences of immunogenic peptides derived from the principal neutralizing determinant of the HIV-1 envelope glycoprotein gp120. Biochemistry 30, 9187-9194.
6. Clements, G.J., Price-Jones, M.J., Stephens, P.E., Sutton, C., Schulz, T.F., Clapham, P.R., McKeating, J.A., McClure, M.O., Thomson, S., Marsh, M., Kay, J., Weiss, R.A., and Moore, J.P. (1991). The V3 loops of the HIV-1 and HIV-2 surface glycoproteins contain proteolytic cleavage sites: a possible function in viral fusion? AIDS Res. Hum. Retroviruses 7, 3-16.
7. Couch, R.B. (1996). Rhinoviruses. In: Fields Virology, Vol. 1, 3rd ed., B.N. Fields, D.M. Knipe, P.M. Howley, R.M. Chanock, J.L. Melnick, T.P. Monath, B. Roizman and S.E. Straus, eds. (Philadelphia: Lippincott-Raven), pp. 713-734.
8. Crabbe, M.J.C., Evans, D.J., and Almond, J.W. (1990). Modelling of poliovirus HIV-1 antigen chimaeras. FEBS Letters 271, 194-198.
9. Creighton, T.E. (1988). Disulfide bonds and protein stability. Bioessays 8, 57-63.
10. de Lorimier, R., Moody, M.A., Haynes, B.F., and Spicer, L.D. (1994). NMR-derived solution conformations of a hybrid synthetic peptide containing multiple epitopes of envelope protein gp120 from the RF strain of human immunodeficiency virus. Biochemistry 33, 2055-2062.
11. Dedieu, J.-F., Ronco, J., van der Werf, S., Hogle, J.M., Henin, Y., and Girard, M. (1992). Poliovirus chimeras expressing sequences from the principal neutralization domain of human immunodeficiency virus type 1. J. Virol. 66, 3161-3167.
12. Dick, E.C., and Inhorn, S.L. (1987). Rhinoviruses. In: Textbook of Pediatric Infectious Diseases, R.D. Feigin and J.D. Cherry, eds. (Philadelphia, Pennsylvania: W.B. Saunders Co.), pp. 1539-1558.
13. Englund, G., Hoggan, M., Theodore, T., and Martin, M. (1991). A novel HIV-1 isolate containing alterations affecting the NF-κB element. Virology 181, 150-157.
14. Gallo, R.C., Salahuddin, S.Z., Popovic, M., Shearer, G.M., Kaplan, M., Haynes, B.F., Palker, T.J., Redfield, R., Oleske, J., Safai, B., White, G., Foster, P., and Markham, P.D. (1984). Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS. Science 224, 500-503.
15. Ghiara, J.B., Stura, E.A., Stanfield, R.L., Profy, A.T., and Wilson, I.A. (1994). Crystal structure of the principal neutralization site of HIV-1. Science 264, 82-85.
16. Gorny, M.K., Xu, J.-Y., Karwowska, S., Buchbinder, A., and Zolla-Pazner, S. (1993). Repertoire of neutralizing human monoclonal antibodies specific for the V3 domain of HIV-1 gp 120. J. Immunol. 150, 635-643.
17. Gupta, G., Anantharamaiah, G.M., Scott, D.R., Eldridge, J.H., and Myers, G. (1993). Solution structure of the V3 loop of a Thailand HIV isolate. J. Biomol. Struct. Dyn. 11, 345-366.
18. Hastings, G.Z., Francis, M.J., Rowlands, D.J., and Chain, B.M. (1993a). Antigen processing and presentation of human rhinovirus to CD4 T cells is facilitated by binding to cellular receptors for virus. Eur. J. Immunol. 23, 1340-1345.
19. Hastings, G.Z., Francis, M.J., Rowlands, D.J., and Chain, B.M. (1993b). Epitope analysis of the T cell response to a complex antigen: proliferative responses to human rhinovirus capsids. Eur. J. Immunol. 23, 2300-2305.
20. Jones, T.A. (1978). A graphic models building and refinement system for macromolecules. J. Appl. Crystallogr. 11, 268-272.
21. Kraulis, P.J. (1991). MOLSCRIPT: a program to produce both detailed and schematic plots of protein structure. J. Appl. Crystallogr. 24, 946-950.
22. Lee, W.-m., Monroe, S.S., and Rueckert, R.R. (1993). Role of maturation cleavage in infectivity of picornaviruses: activation of an infectosome. J. Virol. 67, 2110-2122.
23. Mann, D.L., O'Brien, S.J., Gilbert, D.A., Reid, Y., Popovic, M., Read-Connole, E., Gallow, R.C., and Gazdar, A.F. (1989). Origin of the HIV-susceptible human CD4+ cell line H9. AIDS Res. Hum. Retroviruses 5, 253-255.
24. Matsumura, M., and Matthews, B.W. (1991). Stabilization of functional proteins by introduction of multiple disulfide bonds. Methods Enzymol. 202, 336-356.
25. Mizutani, S., and Colonno, R.J. (1985). In vitro synthesis of an infectious RNA from cDNA clones of human rhinovirus 14. J. Virol. 56, 628-632.
26. Ohno, T., Terada, M., Yoneda, Y., Shea, K.W., Chambers, R.F., Stroka, D.M., Nakamura, M., and Kufe, D.W. (1991). A broadly neutralizing monoclonal antibodythat recognizes the V3 region of human immunodeficiency virus type 1 glycoprotein gp120. Proc. Natl. Acad. Sci. USA 88, 10726-10729.
27. Palker, T.J., Matthews, T.J., Langlois, A., Tanner, M.E., Martin, M.E., Scearce, R.M., Kim, J.E., Berzofsky, J.A., Bolognesi, D.P., and Haynes, B.F. (1989). Polyvalent human immunodeficiency virus synthetic immunogen comprised of envelope gp120 T helper cell sites and B cell neutralization epitopes. J. Immunol. 142, 3612-3619.
28. Resnick, D.A., Smith, A.D., Geisler, S.C., Zhang, A., Arnold, E., and Arnold, G.F. (1995). Chimeras from a human rhinovirus 14-human immunodeficiency virus type 1 (HIV-1) V3 loop seroprevalence library induce neutralizing responses against HIV-1. J. Virol. 69, 2406-2411.
29. Rini, J.M., Stanfield, R.L., Stura, E.A., Salinas, P.A., Profy, A.T., and Wilson, I.A. (1993). Crystal structure of a human immunodeficiency virus type 1 neutralizing antibody, 50.1, in complex with its V3 loop peptide antigen. Proc. Natl. Acad. Sci. USA 90, 6325-6329.
30. Rossmann, M.G., Arnold, E., Erickson, J.W., Frankenberger, E.A., Griffith, J.P., Hecht, H.-J., Johnson, J.E., Kamer, G., Luo, M., Mosser, A.G., Rueckert, R.R., Sherry, B., and Vriend, G. (1985). Structure of a human common cold virus and functional relationships to other picornaviruses. Nature 317, 145-153.
31. Rueckert, R.R. (1996). Picornaviridae: the viruses and their replication. In: Fields Virology, Vol. 1, 3rd ed. B.N. Fields, D.M. Knipe, P.M. Howley, R.M. Chanock, J.L. Melnick, T.P. Monath and B. Roizman, eds. (New York: Lippincott-Raven Publishers), pp. 609-654.
32. Sanger, F., Nicklen, S., and Coulson, A.R. (1977). DNA sequencing with chain-terminating inhibitors. Proc. Natl. Acad. Sci. USA 74, 5463-5467.
33. Sherry, B., and Rueckert, R.R. (1985). Evidence for at least two dominant neutralization antigens on human rhinovirus 14. J. Virol. 53, 137-143.
34. Sherry, B., Mosser, A.G., Colonno, R.J., and Rueckert, R.R. (1986). Use of monoclonal antibodies to identify four neutralization immunogens on a common cold picornavirus, human rhinovirus 14. J. Virol. 57, 246-257.
35. Smith, A.D., Geisler, S.C., Chen, A.A., Resnick, D.A., Roy, B.M., Lewi, P.J., Arnold, E., and Arnold, G.F. (1998). Human rhinovirus type 14:human immunodeficiency virus type 1 (HIV-1) V3 loop chimeras from a combinatorial library induce potent neutralizing antibody responses against HIV-1. J. Virol. 72, 651-659.
36. Smith, A.D., Resnick, D.A., Zhang, A., Geisler, S.C., Arnold, E., and Arnold, G.F. (1994). Use of random systematic mutagenesis to generate viable human rhinovirus 14 chimeras displaying HIV-1 V3 loop sequences. J. Virol. 68, 575-579.
37. Tolman, R.L., Bednarek, M.A., Johnson, B.A., Leanza, W.J., Marburg, S., Underwood, D.J., Emini, E.A., and Conley, A.J. (1993). Cyclic V3-loop-related HIV-1 conjugate vaccines. Int. J. Pept. Protein Res. 41, 455-466.
38. Vieira, J., and Messing, J. (1987). Production of single-stranded plasmid DNA. Methods Enzymol. 153, 3-11.
39. Vogel, T., Kurth, R., and Norley, S. (1994). The majority of neutralizing Abs in HIV-1-infected patients recognize linear V3 loop sequences. J. Immunol. 153, 1895-1904.
40. Wang, J.J.G., Steel, S., Wisniewolski, R., and Wang, C.Y. (1986). Detection of antibodies to human T-lymphotropic virus type III by using a synthetic peptide of 21 amino acid residues corresponding to a highly antigenic segment of gp41 envelope glycoprotein. Proc. Natl. Acad. Sci. USA 83, 6159-6163.
41. Wang, C.Y., Looney, D.J., Li, M.L., Walfield, A.M., Ye, J., Hosein, B., Tam, J.P., and Wong-Staal, F. (1991). Long-term high-titer neutralizing activity induced by octameric synthetic HIV-1 antigen. Science 254, 285-288.
42. White-Scharf, M.E., Potts, B.J., Smith, L.M., Sokolowski, K.A., Rusche, J.R., and Silver, S. (1993). Broadly neutralizing monoclonal antibodies to the V3 region of HIV-1 can be elicited by peptide immunization. Virology 192, 197-206.
43. Willey, R.L., Smith, D.H., Lasky, L.A., Theodore, T.S., Earl, P.L., Moss, B., Capon, D.J., and Martin, M.A. (1988). In vitro mutagenesis identifies a region within the envelope gene of the human immunodeficiency virus that is critical for infectivity. J. Virol. 62, 139-147.
44. Zhang, A., Nanni, R.G., Li, T., Arnold, G.F., Oren, D.A., Jacobo-Molina, A., Williams, R.L., Kamer, G., Rubenstein, D.A., Li, Y., Rozhon, E., Cox, S., Buontempo, P., O'Connell, J., Schwartz, J., Miller, G., Bauer, B., Versace, R., Pinto, P., Ganguly, A., Girijavallabhan, V., and Arnold, E. (1993). Structure determination of antiviral compound SCH 38057 complexed with human rhinovirus 14. J. Mol. Biol. 230, 857-867.